Cell-surface and mitotic-spindle RHAMM: Moonlighting or dual oncogenic functions?

Journal of Cell Science

Volumn 121, Issue 7, 2008, Pages 925-932

  Maxwell, Christopher Alan ^a   McCarthy, James ^b   Turley, Eva ^c  

^a BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

CD44; RHAMM (HMMR); Unconventional protein export

Indexed keywords

AURORA A KINASE; BRCA1 ASSOCIATED RING DOMAIN PROTEIN 1; BRCA1 PROTEIN; CA 125 ANTIGEN; CANCER VACCINE; CD51 ANTIGEN; CYTOPLASM PROTEIN; DYNEIN ADENOSINE TRIPHOSPHATASE; EPIDERMAL GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 2; GALECTIN 1; GALECTIN 3; GAMMA TUBULIN; GELATINASE B; GLUCOSE 6 PHOSPHATE ISOMERASE; HEAT SHOCK PROTEIN 70; HERMES ANTIGEN; HYALURONAN MEDIATED MOTILITY RECEPTOR; KARYOPHERIN; MATRIX METALLOPROTEINASE 14; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; POLO LIKE KINASE 1; RAN PROTEIN; SYNTAXIN 2; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; VERY LATE ACTIVATION ANTIGEN 3;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; BREAST CANCER; CANCER IMMUNIZATION; CARCINOGENESIS; CELL SURFACE; CLINICAL TRIAL; DISEASE COURSE; GENE DELETION; GENE MUTATION; GENOMIC INSTABILITY; HUMAN; INFLAMMATORY DISEASE; MITOSIS SPINDLE; MULTIPLE MYELOMA; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; TUMOR PROMOTION; WOUND HEALING;

ANIMALS; ANTIGENS, CD44; BRCA1 PROTEIN; EXTRACELLULAR MATRIX PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MITOTIC SPINDLE APPARATUS; MODELS, BIOLOGICAL; NEOPLASMS; PROTEIN TRANSPORT;

EID: 43149106462     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.022038     Document Type: Article

References (78)

1. Adamia, S., Maxwell, C. A. and Pilarski, L. M. (2005). Hyaluronan and hyaluronan synthases: potential therapeutic targets in cancer. Curr. Drug Targets Cardiovasc. Haematol. Disord. 5, 3-14.
2. Agnantis, N. J., Goussia, A. C., Batistatou, A. and Stefanou, D. (2004). Tumor markers in cancer patients, an update of their prognostic significance. Part II. In Vivo 18, 481-488.
3. Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J. and Clarke, M. F. (2003). Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. USA 100, 3983-3988.
4. Assmann, V., Jenkinson, D., Marshall, J. F. and Hart, I. R. (1999). The intracellular hyaluronan receptor RHAMM/IHABP interacts with microtubules and actin filaments. J. Cell Sci. 112, 3943-3954.
5. Auvinen, P., Tammi, R., Parkkinen, J., Tammi, M., Agren, U., Johansson, R., Hirvikoski, P., Eskelinen, M. and Kosma, V. M. (2000). Hyaluronan in peritumoral stroma and malignant cells associates with breast cancer spreading and predicts survival. Am. J. Pathol. 156, 529-536.
6. Baer, R. and Ludwig, T. (2002). The BRCA1/BARD1 heterodimer, a tumor suppressor complex with ubiquitin E3 ligase activity. Curr. Opin. Genet. Dev. 12, 86-91.
7. Banerji, S., Wright, A. J., Noble, M., Mahoney, D. J., Campbell, I. D., Day, A. J. and Jackson, D. G. (2007). Structures of the Cd44-hyaluronan complex provide insight into a fundamental carbohydrate-protein interaction. Nat. Struct. Mol. Biol. 14, 234-239.
8. Bild, A. H., Potti, A. and Nevins, J. R. (2006). Linking oncogenic pathways with therapeutic opportunities. Nat. Rev. Cancer 6, 735-741.
9. Bourguignon, L. Y., Gilad, E. and Peyrollier, K. (2007). Heregulin-mediated ErbB2-ERK signaling activates hyaluronan synthases leading to CD44-dependent ovarian tumor cell growth and migration. J. Biol. Chem. 282, 19426-19441.
10. Califice, S., Castronovo, V. and Van Den Brule, F. (2004). Galectin-3 and cancer (Review). Int. J. Oncol. 25, 983-992.
11. Chivasa, S., Simon, W. J., Yu, X. L., Yalpani, N. and Slabas, A. R. (2005). Pathogen elicitor-induced changes in the maize extracellular matrix proteome. Proteomics 5, 4894-4904.
12. Chivasa, S., Hamilton, J. M., Pringle, R. S., Ndimba, B. K., Simon, W. J., Lindsey, K. and Slabas, A. R. (2006). Proteomic analysis of differentially expressed proteins in fungal elicitor-treated Arabidopsis cell cultures. J. Exp. Bot. 57, 1553-1562.
13. Cho, R. J., Huang, M., Campbell, M. J., Dong, H., Steinmetz, L., Sapinoso, L., Hampton, G., Elledge, S. J., Davis, R. W. and Lockhart, D. J. (2001). Transcriptional regulation and function during the human cell cycle. Nat. Genet. 27, 48-54.
14. Day, A. J. and Prestwich, G. D. (2002). Hyaluronan-binding proteins: tying up the giant. J. Biol. Chem. 277, 4585-4588.
15. Entwistle, J., Hall, C. L. and Turley, E. A. (1996). HA receptors: regulators of signalling to the cytoskeleton. J. Cell. Biochem. 61, 569-577.
16. Epstein, J. I., Amin, M., Boccon-Gibod, L., Egevad, L., Humphrey, P. A., Mikuz, G., Newling, D., Nilsson, S., Sakr, W., Srigley, J. R. et al. (2005). Prognostic factors and reporting of prostate carcinoma in radical prostatectomy and pelvic lymphadenectomy specimens. Scand. J. Urol. Nephrol. Suppl. 2005, 34-63.
17. Evanko, S. P., Tammi, M. I., Tammi, R. H. and Wight, T. N. (2007). Hyaluronan-dependent pericellular matrix. Adv. Drug Deliv. Rev. 59, 1351-1365.
18. Giannopoulos, K. and Schmitt, M. (2006). Targets and strategies for T-cell based vaccines in patients with B-cell chronic lymphocytic leukemia. Leuk. Lymphoma 47, 2028-2036.
19. Gotte, M. and Yip, G. W. (2006). Heparanase, hyaluronan, and CD44 in cancers: a breast carcinoma perspective. Cancer Res. 66, 10233-10237.
20. Greiner, J., Ringhoffer, M, Taniguchi, M., Schmitt, A., Kirchner, D., Krahn, G., Heilmann, V., Gschwend, J., Bergmann, L., Dohner, H. et al. (2002). Receptor for hyaluronan acid-mediated motility (RHAMM) is a new immunogenic leukemia-associated antigen in acute and chronic myeloid leukemia. Exp. Hematol. 30, 1029-1035.
21. Groen, A. C., Cameron, L. A., Coughlin, M., Miyamoto, D. T., Mitchison, T. J. and Ohi, R. (2004). XRHAMM functions in ran-dependent microtubule nucleation and pole formation during anastral spindle assembly. Curr. Biol. 14, 1801-1811.
22. Gullo, C., Au, M., Feng, G. and Teoh, G. (2006). The biology of Ku and its potential oncogenic role in cancer. Biochim. Biophys. Acta 1765, 223-234.
23. Hall, C. L., Yang, B., Yang, X., Zhang, S., Turley, M., Samuel, S., Lange, L. A., Wang, C., Curpen, G. D., Savani, R. C. et al. (1995). Overexpression of the hyaluronan receptor RHAMM is transforming and is also required for H-ras transformation. Cell 82, 19-26.
24. Hamilton, S. R., Fard, S. F., Paiwand, F. F., Tolg, C., Veiseh, M., Wang, C., McCarthy, J. B., Bissell, M. J., Koropatnick, J. and Turley, E. A. (2007). The hyaluronan receptors CD44 and Rhamm (CD168) form complexes with ERK1,2 that sustain high basal motility in breast cancer cells. J. Biol. Chem. 282, 16667-16680.
25. Hardwick, C., Hoare, K., Owens, R., Hohn, H. P., Hook, M., Moore, D., Cripps, V., Austen, L., Nance, D. M. and Turley, E. A. (1992). Molecular cloning of a novel hyaluronan receptor that mediates tumor cell motility. J. Cell Biol. 117, 1343-1350.
26. Hathout, Y. (2007). Approaches to the study of the cell secretome. Expert Rev. Proteomics 4, 239-248.
27. Hirai, Y., Nelson, C. M., Yamazaki, K., Takebe, K., Przybylo, J., Madden, B. and Radisky, D. C. (2007). Non-classical export of epimorphin and its adhesion to alphav-integrin in regulation of epithelia] morphogenesis. J. Cell Sci. 120, 2032-2043.
28. Hofmann, M., Fieber, C., Assmann, V., Gottlicher, M., Sleeman, J., Plug, R., Howells, N., von Stein, O., Ponta, H. and Herrlich, P. (1998). Identification of IHABP, a 95 kDa intracellular hyaluronate binding protein. J. Cell Sci. 111, 1673-1684.
29. Hsu, L. C., Doan, T. P. and White, R. L. (2001). Identification of a gamma-tubulin-binding domain in BRCA1. Cancer Res. 61, 7713-7718.
30. Joukov, V., Groen, A. C., Prokhorova, T., Gerson, R., White, E., Rodriguez, A., Walter, J. C. and Livingston, D. M. (2006). The BRCA1/ BARD1 heterodimer modulates ran-dependent mitotic spindle assembly. Cell 127, 539-552.
31. Kauffman, E. C., Robinson, V. L., Stadler, W. M., Sokoloff, M. H. and Rinker-Schaeffer, C. W. (2003). Metastasis suppression: the evolving role of metastasis suppressor genes for regulating cancer cell growth at the secondary site. J. Urol. 169, 1122-1133.
32. Kuhn, S., Koch, M., Nubel, T., Ladwein, M., Antolovic, D., Klingbeil, P., Hildebrand, D., Moldenhauer, G., Langbein, L., Franke, W. W. et al. (2007). A complex of EpCAM, claudin-7, CD44 variant isoforms, and tetraspanins promotes colorectal cancer progression. Mol. Cancer Res. 5, 553-567.
33. Liska, A. J., Popov, A. V., Sunyaev, S., Coughlin, P., Habermann, B., Shevchenko, A., Bork, P. and Karsenti, E. (2004). Homology-based functional proteomics by mass spectrometry: application to the Xenopus microtubule-associated proteome. Proteomics 4, 2707-2721.
34. Liu, R., Wang, X., Chen, G. Y., Dalerba, P., Gurney, A., Hoey, T., Sherlock, G., Lewicki, J., Shedden, K. and Clarke, M. F. (2007). The prognostic role of a gene signature from tumorigenic breast-cancer cells. N. Engl. J. Med. 356, 217-226.
35. Lopez, J. I., Camenisch, T. D., Stevens, M. V., Sands, B. J., McDonald, J. and Schroeder, J. A. (2005). CD44 attenuates metastatic invasion during breast cancer progression. Cancer Res. 65, 6755-6763.
36. Maxwell, C. A., Keats, J. J., Crainie, M., Sun, X., Yen, T., Shibuya, E., Hendzel, M., Chan, G. and Pilarski, L. M. (2003). RHAMM is a centrosomal protein that interacts with dynein and maintains spindle pole stability. Mol. Biol. Cell 14, 2262-2276.
37. Maxwell, C. A., Rasmussen, E., Zhan, F., Keats, J. J, Adamia, S., Strachan, E., Crainie, M., Walker, R., Belch, A. R., Pilarski, L. M. et al. (2004). RHAMM expression and isoform balance predict aggressive disease and poor survival in multiple myeloma. Blood 104, 1151-1158.
38. Maxwell, C. A., Keats, J. J., Belch, A. R., Pilarski, L. M. and Reiman, T. (2005). Receptor for hyaluronan-mediated motility correlates with centrosome abnormalities in multiple myeloma and maintains mitotic integrity. Cancer Res. 65, 850-860.
39. Milner, C. M., Higman, V. A. and Day, A. J. (2006). TSG-6: a pluripotent inflammatory mediator? Biochem. Soc. Trans. 34, 446-450.
40. Muller, C., Paupert, J., Monferran, S. and Salles, B. (2005). The double life of the Ku protein: facing the DNA breaks and the extracellular environment. Cell Cycle 4, 438-441.
41. Nangia-Makker, P., Nakahara, S., Hogan, V. and Raz, A. (2007). Galectin-3 in apoptosis, a novel therapeutic target. J. Bioenerg. Biomembr. 39, 79-84.
42. Naor, D., Nedvetzki, S., Walmsley, M., Yayon, A, Turley, E. A., Golan, I., Caspi, D., Sebban, L. E., Zick, Y., Garin, T. et al. (2007). CD44 involvement in autoimmune inflammations: the lesson to be learned from CD44-targeting by antibody or from knockout mice. Ann. N. Y. Acad. Sci. 1110, 233-247.
43. Nedvetzki, S., Gonen, E., Assayag, N., Reich, R., Williams, R. O., Thurmond, R. L., Huang, J. F., Neudecker, B. A., Wang, F. S., Turley, E. A. et al. (2004). RHAMM, a receptor for hyaluronan-mediated motility, compensates for CD44 in inflamed CD44-knockout mice: a different interpretation of redundancy. Proc. Natl. Acad. Sci. USA 101, 18081-18086.
44. Neve, R. M., Chin, K., Fridlyand, J., Yeh, J., Baehmer, F. L., Fevr, T., Clark, L., Bayani, N., Coppe, J. P., Tong, F. et al. (2006). A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 10, 515-527.
45. Nickel, W. (2005). Unconventional secretory routes: direct protein export across the plasma membrane of mammalian cells. Traffic 6 607-614.
46. Nousiainen, M., Sillje, H. H., Sauer, G., Nigg, E. A. and Korner, R. (2006). Phosphoproteome analysis of the human mitotic spindle. Proc. Natl. Acad. Sci. USA 103, 5391-5396.
47. Partridge, E. A., Le Roy, C., Di Guglielmo, G. M., Pawling, J., Cheung, P., Granovsky, M., Nabi, I. R., Wrana, J. L. and Dennis, J. W. (2004). Regulation of cytokine receptors by Golgi N-glycan processing and endocytosis. Science 306, 120-124.
48. Paupert, J., Dauvillier, S., Salles, B. and Muller, C. (2007). Transport of the leaderless protein Ku on the cell surface of activated monocytes regulates their migratory abilities. EMBO Rep. 8, 583-588.
49. Prudovsky, I., Tarantini, F., Landriscina, M., Neivandt, D., Soldi, R., Kirov, A., Small, D., Kathir, K. M., Rajalingam, D. and Kumar, T. K. (2007). Secretion without Golgi. J. Cell. Biochem. doi: 10.1002/ jcb.21513.
50. Pujana, M. A., Han, J. D., Starita, L. M., Stevens, K. N., Tewari, M., Ahn, J. S., Rennert, G., Moreno, V., Kirchhoff, T., Gold, B. et al. (2007). Network modeling links breast cancer susceptibility and centrosome dysfunction. Nat. Genet. 39, 1338-1349.
51. Radisky, D. C., Hirai, Y. and Bissell, M. J. (2003). Delivering the message: epimorphin and mammary epithelial morphogenesis. Trends Cell Biol. 13, 426-434.
52. Rajalingam, D., Kumar, T. K., Soldi, R., Graziani, I., Prudovsky, I. and Yu. C. (2005). Molecular mechanism of inhibition of nonclassical FGF-1 export. Biochemistry 44, 15472-15479.
53. Rizki, A., Mott, J. D. and Bissell, M.J. (2007). Polo-like kinase 1 is involved in invasion through extracellular matrix. Cancer Res. 67, 11106-11110.
54. Samuel, S. K., Hurta, R. A., Spearman, M. A., Wright, J. A., Turley, E. A. and Greenberg, A. H. (1993). TGF-beta 1 stimulation of cell locomotion utilizes the hyaluronan receptor RHAMM and hyaluronan. J. Cell Biol. 123, 749-758.
55. Schmitt, M., Schmitt, A., Rojewski, M. T., Chen, J., Giannopoulos, K., Fei, F., Yu, Y., Gotz, M., Heyduk, M., Ritter, G. et al. (2007). RHAMM-R3 peptide vaccination in patients with acute myeloid leukemia, myelodysplastic syndrome and multiple myeloma elicits immunological and clinical responses. Blood 111, 1357-1365.
56. Sheridan, C., Kishimoto, H., Fuchs, R. K., Mehrotra, S., Bhat-Nakshatri, P., Turner, C. H., Goulet, R., Badve, S., Jr and Nakshatri, H. (2006). CD44+/CD24-breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis. Breast Cancer Res. 8, R59.
57. Shipitsin, M., Campbell, L. L., Argani, P., Weremowicz, S., Bloushtain-Qimron, N., Yao, J., Nikolskaya, T., Serebryiskaya, T., Beroukhim, R., Hu, M. et al. (2007). Molecular definition of breast tumor heterogeneity. Cancer Cell 11, 259-273.
58. Simpson, J. C., Mateos, A. and Pepperkok, R. (2007). Maturation of the mammalian secretome. Genome Biol. 8, 211.
59. Slevin, M., Krupinski, J., Gaffney, J., Matou, S., West, D., Delisser, H., Savani, R. C. and Kumar, S. (2007). Hyaluronan-mediated angiogenesis in vascular disease: uncovering RHAMM and CD44 receptor signaling pathways. Matrix Biol. 26, 58-68.
60. Starita, L. M., Machida, Y., Sankaran, S., Elias, J. E., Griffin, K., Schlegel, B. P., Gygi, S. P. and Parvin, J. D. (2004). BRCA1-dependent ubiquitination of gamma-tubulin regulates centrosome number. Mol. Cell. Biol. 24, 8457-8466.
61. Takenaka, Y., Fukumori, T. and Raz, A. (2004). Galectin-3 and metastasis. Glycoconj. J. 19, 543-549.
62. Tang, D. G., Patrawala, L., Calhoun, T., Bhatia, B., Choy, G., Schneider-Broussard, R. and Jeter, C. (2007). Prostate cancer stem/ progenitor cells: identification, characterization, and implications. Mol. Carcinog. 46, 1-14.
63. Tjalsma, H., Pluk, W., van den Heuvel, L. P., Peters, W. H., Roelofs, R. and Swinkels, D. W. (2006). Proteomic inventory of "anchorless" proteins on the colon adenocarcinoma cell surface. Biochim. Biophys. Acta 1764, 1607-1617.
64. Tolg, C., Hamilton, S. R., Nakrieko, K. A., Kooshesh, F., Walton, P., McCarthy, J. B., Bissell, M. J. and Turley, E. A. (2006). Rhamm-/- fibroblasts are defective in CD44-mediated ERK1,2 motogenic signaling, leading to defective skin wound repair. J. Cell Biol. 175, 1017-1028.
65. Toole, B. P. (2004). Hyaluronan: from extracellular glue to pericellular cue. Nat. Rev. Cancer 4, 528-539.
66. Turley, E. A. (1982). Purification of a hyaluronate-binding protein fraction that modifies cell social behavior. Biochem. Biophys. Res. Commun. 108, 1016-1024.
67. Turley, E. A, Austen, L., Vandeligt, K. and Clary, C. (1991). Hyaluronan and a cell-associated hyaluronan binding protein regulate the locomotion of ras-transformed cells. J. Cell Biol. 112, 1041-1047.
68. Turley, E. A., Noble, P. W. and Bourguignon, L. Y. (2002). Signaling properties of hyaluronan receptors. J. Biol. Chem. 277, 4589-4592.
69. Vargo-Gogola, T. and Rosen, J. M. (2007). Modelling breast cancer: one size does not fit all. Nat. Rev. Cancer 7, 659-672.
70. Venkitaraman, A. R. (2002). Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell 108, 171-182.
71. Wang, C., Thor, A. D., Moore, D. H., 2nd, Zhao, Y., Kerschmann, R., Stern, R., Watson, P. H. and Turley, E. A. (1998). The overexpression of RHAMM, a hyaluronan-binding protein that regulates ras signaling, correlates with overexpression of mitogen-activated protein kinase and is a significant parameter in breast cancer progression. Clin. Cancer Res. 4, 567-576.
72. Wang, S. J, Wreesmann, V. B. and Bourguignon, L. Y. (2007). Association of CD44 V3-containing isoforms with tumor cell growth, migration, matrix metalloproteinase expression, and lymph node metastasis in head and neck cancer. Head Neck 29, 550-558.
73. Wernicke, M., Pineiro, L. C., Caramutti, D., Dorn, V. G., Raffo, M. M., Guixa, H. G., Telenta, M. and Morandi, A. A. (2003). Breast cancer stromal myxoid changes are associated with tumor invasion and metastasis: a central role for hyaluronan. Mod. Pathol. 16, 99-107.
74. Whitfield, M. L., Sherlock, G., Saldanha, A. J., Murray, J. L, Ball, C. A., Alexander, K. E., Matese, J. C., Perou, C. M., Hurt, M. M., Brown, P. O. et al. (2002). Identification of genes periodically expressed in the human cell cycle and their expression in tumors. Mol. Biol. Cell 13, 1977-2000.
75. Wielenga, V. J., van der Neut, R., Offerhaus, G. J. and Pals, S. T. (2000). CD44 glycoproteins in colorectal cancer: expression, function, and prognostic value. Adv. Cancer Res. 77, 169-187.
76. Xu, X., Weaver, Z., Linke, S. P., Li, C., Gotay, J., Wang, X. W., Harris, C. C., Ried, T. and Deng, C. X. (1999). Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells. Mol. Cell 3, 389-395.
77. Yang, B., Yang, B. L., Savani, R. C. and Turley, E. A. (1994). Identification of a common hyaluronan binding motif in the hyaluronan binding proteins RHAMM, CD44 and link protein. EMBO J. 13, 286-296.
78. Zehe, C., Engling, A., Wegehingel, S., Schafer, T. and Nickel, W. (2006). Cell-surface heparan sulfate proteoglycans are essential components of the unconventional export machinery of FGF-2. Proc. Natl. Acad. Sci. USA 103, 15479-15484.